Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Herbon Polysaccharide Bio-tech is a specialized biopharmaceutical company based in China that focuses on the research, development, and large-scale production of high-purity animal-derived polysaccharides. The company is a prominent manufacturer of critical anticoagulant ingredients, including Heparin Sodium and Enoxaparin Sodium APIs. Operating from GMP-compliant facilities in Hebei, Herbon provides high-quality glycosaminoglycan products to the global pharmaceutical and nutraceutical industries. Their expertise spans the entire value chain from raw material extraction to the production of refined active pharmaceutical ingredients for cardiovascular and hematological applications. The company is recognized for its technical capabilities in purification processes and its role in the global supply of essential blood-thinning medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Herbon Polysaccharide Bio-tech.